Diabetes Management Market By Device Type, (Monitoring Devices, Diagnostic Devices, Insulin Delivery Devices), By Therapeutics, (Injectable, Oral Drugs), Industry analysis, Trends, Estimation & forecast, 2016 - 2024

January 2019

 ERC 4482


The term diabetes is referred to a disease which reduces the capability of the body to produce or respond to the hormone insulin, resulting in abnormal metabolism of carbohydrates and elevated levels of glucose in the blood. Scientifically, diabetes is also known as mellitus, and is classified as disorganization of pancreases to produce insulin (Type I) and unresponsiveness of body cells to the produced insulin (Type II) or both. This illness specifically results in increase in thrust and hunger. The cases of type II diabetes are majorly witnessed all around the world as a result of increased obesity, urbanization, poor diet and substandard healthcare conditions. The main goal of diabetes management is, as soon as possible, to restore carbohydrate metabolism to a normal state. The global market for diabetes is extremely profitable for drug and device manufacturers as treatment majorly demands therapeutic and diagnostic management.

Diabetes Management Market Determinants

The key factor driving the growth of global diabetes management market is the increasing diabetic patients and increasing healthcare awareness. As per the data revealed by National Diabetes Statistics Report, in 2015, an estimated 23.1 million people, or 7.2% of the U.S. population had diagnosed diabetes. Moreover, increase in collaborations & associations are creating better avenues to attain high effectiveness. In addition to this, increasing occurrence of type I and type II diabetes as a result of high obese population is highly stimulating the market growth. However, high costs related to diabetes management, limited infrastructure for management and counterfeiting of drugs are major restraining factors for global diabetes management market. On the other hand, developing economies are expected to provide huge growth potential for the market, during the few years.

market determinants-impact analysis

Diabetes Management Market Segment Analysis

The diabetes management market is segmented by device type, therapeutics, and geography. On the basis of device type, the global diabetes management further segmented into monitoring devices, diagnostic devices, insulin delivery devices and others. By therapeutics, the global diabetes management is segmented into an injectable and oral drug. On the basis of geography, the global diabetes management is segmented into North America, Europe, Asia Pacific and Rest of World.

The major market players are adopting various strategies in order to strengthen their market position such as expansion, in 2017. The key companies in global diabetes management market include Abbott Laboratories, Bayer AG, Bristol-Myers Squibb, Eli Lilly and Co., Sanofi, Dexcom, Medtronic and Novo Nordisk A/S. Currently, Abbott, Dexcom, and Medtronic.

Diabetes Management Market Segmentation

• By Device Type
    o Monitoring Devices
             o Blood Glucose Meters
             o Lancets
             o Blood Sampling Devices
    o Diagnostic Devices
             o Hemoglobin A1c
             o Hemoglobin A1c Kits
             o Hemoglobin A1c Meters

    o Insulin Delivery Devices
             o Insulin Pumps
             o Insulin Pens
             o Disposable Insulin Pens
             o Insulin Syringes
             o Reusable Insulin Pens
             o Others (artificial pancreas, artificial pancreas, commercial software)

• By Therapeutics
    o Injectable
             o Insulin
             o Exenatide
    o Oral Drugs
             o Metformin
             o Alpha-Glucosidase Inhibitors
             o Meglitinides
             o Dipeptidyl Inhibitors
             o Thiazolidinedione
             o Combination Medications

By Geography
   o North America
   o Europe
   o Asia-Pacific
   o Rest of World

Diabetes Management Market Key Players

• Abbott Laboratories
• Dexcom
• Novo Nordisk A/S
• Bristol-Myers Squibb
• Eli Lilly and Co.
• Bayer AG
• Medtronic
• Abbott

Please fill in the form below to Request for Customized Report
Your personal details are safe and secured with us. Privacy Policy

To request sample copy of this report, please complete the form below verified and secure

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Your personal details are safe and secured with us. Privacy Policy

    What Information does this report contain?

    • What was the market size of the Diabetes Management Market in 2016 and the expected market size by 2024, along with the growth rate?
    • An in-depth analysis of the current impacting factors, opportunities and challenges/restraints in the market
    • Which are the largest revenue generating products, services or regions, and their comparative growth rate?
    • Which technology is in trend and how would it evolve during the forecast period (2016 - 2024)?
    • Which are the leading companies in the Diabetes Management Market and their competitive positioning basis their market share, product portfolio, strategic attempts and business focus?

Purchase Options

Offers & Discounts

  • Chapter purchase
  • Historical market data
  • Country level data breakdown
  • Free customization*
  • Discounts for first time
  • Special pricing for
              non-business entities


  • We offer 20% free customization on every purchase.

Get in touch!